NFL Legend Turns Cancer Scare Into Life-Saver

A doctor's gloved hand placing red blocks with health symbols on a table

A routine screening caught Tony Romo’s father’s prostate cancer before any symptoms appeared, turning a football fan’s game day into a life-saving wake-up call for millions.

Story Snapshot

Ramiro Romo, age 50, diagnosed days after watching son Tony play at Soldier Field, with no prior symptoms.
Tony Romo and father launched “Tackle Prostate Cancer” with PCEC and 13 NFL teams to push early screening.
Early detection boasts nearly 100% five-year survival rate, per medical experts.
Campaign evolved to Bayer’s “Highlights REAL” in 2026, focusing on advanced cancer management.
Dr. E. David Crawford urges baseline checks at age 35 for all men.

Ramiro Romo’s Sudden Diagnosis

Ramiro Romo attended the Chicago Bears game at Soldier Field on September 23 to cheer his son Tony. Days later, doctors diagnosed him with prostate cancer at age 50. Routine screening revealed the disease despite zero symptoms. This asymptomatic case underscores why preventive checks matter. Tony Romo immediately rallied to amplify the message, partnering with his father for public advocacy. Their story personalizes the stakes for everyday men.

Launch of Tackle Prostate Cancer Program

Tony Romo collaborated with the Prostate Conditions Education Council on the “Tackle Prostate Cancer” initiative. Thirteen NFL teams backed the effort to screen over 100,000 men in one season. The program stressed “Choose to Know” PSA values. Dr. E. David Crawford, PCEC founder, recommended baseline assessments at age 35. Men followed this advice, and early catches proved transformative. The campaign tied sports passion to health responsibility.

Prostate Cancer’s Silent Threat

Nearly 200,000 American men face prostate cancer diagnosis yearly, second-leading cancer killer with over 27,000 deaths. Recent data calls it the top cancer diagnosis for men. Early detection yields nearly 100% five-year survival. Late stages drop odds dramatically. No warning signs plague initial phases, mirroring Ramiro’s experience. Screening debates exist over biopsies and treatments, but facts favor proactive knowledge.

Evolution to Highlights REAL Campaign

Bayer announced “Highlights REAL” on January 29, 2026, featuring Tony and Ramiro Romo. This builds on original efforts, targeting advanced prostate cancer patients and caregivers. It sparks talks on treatment management like NUBEQA. Families need game plans for doctor discussions. Corporate backing adds resources, aligning with values of personal responsibility in health. Sustained advocacy shows real commitment beyond hype.

Short-term boosts include higher screening rates among 35-50-year-olds and less stigma. Long-term, fewer late diagnoses cut costs and save lives. NFL fans gain health literacy. Providers face demand spikes, but early interventions ease burdens. Celebrity stories like Romos’ model effective outreach.

Expert Guidance and Lasting Impact

Dr. Crawford asserts screening saves lives, tailoring schedules per patient. PCEC’s framework empowers choices on PSA, biopsies, treatments. Romos’ platform normalizes talks in sports culture. Pharmaceutical ties raise questions, yet facts support broader awareness. American men over 35 gain vital tools. This precedent urges more athlete-led health drives, blending family bonds with public good.